FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to a compound of formula (XVIII): which can be used for monitoring and studying the metabolism in clinical and preclinical examinations. The invention also concerns a method for preparing the specified compound.
EFFECT: development of the effective method for preparing the compound.
2 cl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
TRIAZOLPYRIMIDINE COMPOUNDS AND THEIR USE IN TREATMENT OF CANCER | 2019 |
|
RU2793249C2 |
PIPERIDINE DERIVATIVES | 2011 |
|
RU2554353C2 |
NITROGEN-CONTAINING HETEROARYL DERIVATIVES | 2011 |
|
RU2559895C2 |
DERIVATIVES OF PROPIONIC ACIDS AND THEIR USING AS hPPARs ACTIVATORS | 2003 |
|
RU2316539C2 |
OXADIAZOLE-BASED CHANNEL INHIBITORS WITH TRANSIENT POTENTIAL | 2019 |
|
RU2818244C2 |
CHEMICAL COMPOUNDS 637: PYRIDOPYRIMIDINEDIONES AS PDE4 INHIBITORS | 2008 |
|
RU2479584C2 |
NOVEL 2-HETEROARYL-SUBSTITUTED BENZOTHIOPHENES AND BENZOFURANS 709 | 2008 |
|
RU2472789C2 |
IMIDAZOPYRAZINES | 2012 |
|
RU2600327C2 |
N-HYDROXY-BENZAMIDES FOR TREATING CANCER | 2011 |
|
RU2577861C2 |
PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS mGluR5 ANTAGONISTS | 2006 |
|
RU2411237C2 |
Authors
Dates
2012-01-27—Published
2006-06-13—Filed